112 results
8-K
EX-99.1
MLTX
MoonLake Immunotherapeutics - Ordinary Shares
7 May 24
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update
8:01am
) on employee benefit plans
Other comprehensive income (loss)
Comprehensive loss attributable to controlling interests shareholders
Comprehensive loss
8-K
EX-99.1
phjo0lm0lexqc 84d
29 Feb 24
MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and Announces an R&D Day on March 10
8:03am
8-K
EX-99.1
wg8q5i4q8ayg3cliuv
14 Nov 23
MoonLake Immunotherapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
12:00am
8-K
EX-99.1
fh48rt32pb7
10 Aug 23
MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update
8:15am
8-K
EX-1.1
gxs4 b4x4590ag51265
29 Jun 23
Entry into a Material Definitive Agreement
4:13pm
424B5
vdi1663yt jlobb5
29 Jun 23
Prospectus supplement for primary offering
4:02pm